Terms: = Endocrine gland cancer AND EGFR, mENA, 1956, ENSG00000146648, P00533, ERBB1, ERBB AND Staging
20 results:
1.
Rahmanian N; Hosseinimehr SJ; Khalaj A; Noaparast Z; Abedi SM; Sabzevari O
Daru; 2017 May; 25(1):13. PubMed ID: 28464952
[TBL] [Abstract] [Full Text] [Related]
2. Prospective study of cetuximab and gemcitabine in combination with radiation therapy: feasibility and efficacy in locally advanced pancreatic head cancer.
Fiore M; Trodella L; Valeri S; Borzomati D; Floreno B; Ippolito E; Trecca P; Trodella LE; D'Angelillo RM; Ramella S; Coppola R
Radiat Oncol; 2015 Dec; 10():255. PubMed ID: 26670587
[TBL] [Abstract] [Full Text] [Related]
3. Setting the bar: compliance with ovarian cancer quality indicators at a National cancer Institute-designated Comprehensive cancer Center.
Liang MI; ElNaggar AC; Nekkanti S; O'Malley DM; Hade EM; Copeland LJ; Fowler JM; Salani R; Backes FJ; Cohn DE
Gynecol Oncol; 2015 Sep; 138(3):689-93. PubMed ID: 26216728
[TBL] [Abstract] [Full Text] [Related]
4. Relationship between the expression of the extracellular matrix genes SPARC, SPP1, FN1, ITGA5 and ITGAV and clinicopathological parameters of tumor progression and colorectal cancer dissemination.
Viana Lde S; Affonso RJ; Silva SR; Denadai MV; Matos D; Salinas de Souza C; Waisberg J
Oncology; 2013; 84(2):81-91. PubMed ID: 23128103
[TBL] [Abstract] [Full Text] [Related]
5. The epidermal growth factor receptor as a therapeutic target in epithelial ovarian cancer.
Gui T; Shen K
Cancer Epidemiol; 2012 Oct; 36(5):490-6. PubMed ID: 22818908
[TBL] [Abstract] [Full Text] [Related]
6. Expression of tumor necrosis factor-alpha-induced protein 8 in pancreas tissues and its correlation with epithelial growth factor receptor levels.
Liu K; Qin CK; Wang ZY; Liu SX; Cui XP; Zhang DY
Asian Pac J Cancer Prev; 2012; 13(3):847-50. PubMed ID: 22631659
[TBL] [Abstract] [Full Text] [Related]
7. Changing pathology with changing drugs: tumors of the gastrointestinal tract.
Cervera P; Fléjou JF
Pathobiology; 2011; 78(2):76-89. PubMed ID: 21677471
[TBL] [Abstract] [Full Text] [Related]
8. Current status on biologic therapies in the treatment of epithelial ovarian cancer.
Han ES; Lin P; Wakabayashi M
Curr Treat Options Oncol; 2009 Apr; 10(1-2):54-66. PubMed ID: 19381822
[TBL] [Abstract] [Full Text] [Related]
9. [Progress of clinical pathology and application of PET-CT on thyroid carcinoma].
Gao M; Li XL; Yu Y; Sun BC; Li SL; Xu WG
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2006 Jun; 41(6):419-24. PubMed ID: 16927796
[TBL] [Abstract] [Full Text] [Related]
10. Increased toxicity with gefitinib, capecitabine, and radiation therapy in pancreatic and rectal cancer: phase I trial results.
Czito BG; Willett CG; Bendell JC; Morse MA; Tyler DS; Fernando NH; Mantyh CR; Blobe GC; Honeycutt W; Yu D; Clary BM; Pappas TN; Ludwig KA; Hurwitz HI
J Clin Oncol; 2006 Feb; 24(4):656-62. PubMed ID: 16446337
[TBL] [Abstract] [Full Text] [Related]
11. Recombinant anti-egfr immunotoxin 425(scFv)-ETA' demonstrates anti-tumor activity against disseminated human pancreatic cancer in nude mice.
Bruell D; Bruns CJ; Yezhelyev M; Huhn M; Müller J; Ischenko I; Fischer R; Finnern R; Jauch KW; Barth S
Int J Mol Med; 2005 Feb; 15(2):305-13. PubMed ID: 15647848
[TBL] [Abstract] [Full Text] [Related]
12. Clinical and biological characteristics of clear cell carcinomas of the ovary in FIGO stages I-II.
Skírnisdóttir I; Seidal T; Karlsson MG; Sorbe B
Int J Oncol; 2005 Jan; 26(1):177-83. PubMed ID: 15586238
[TBL] [Abstract] [Full Text] [Related]
13. A new prognostic model comprising p53, egfr, and tumor grade in early stage epithelial ovarian carcinoma and avoiding the problem of inaccurate surgical staging.
Skírnisdóttir I; Seidal T; Sorbe B
Int J Gynecol Cancer; 2004; 14(2):259-70. PubMed ID: 15086725
[TBL] [Abstract] [Full Text] [Related]
14. c-erbb-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.
Tomić S; Ilić Forko J; Babić D; Sundov D; Kuret S; Andelinović S
Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic value of DNA quantification in early epithelial ovarian carcinoma.
Valverde JJ; Martin M; García-Asenjo JA; Casado A; Vidart JA; Díaz-Rubio E
Obstet Gynecol; 2001 Mar; 97(3):409-16. PubMed ID: 11239647
[TBL] [Abstract] [Full Text] [Related]
16. Primary endometrioid carcinoma of fallopian tube. Clinicomorphologic study.
Rabczyński J; Ziółkowski P
Pathol Oncol Res; 1999; 5(1):61-6. PubMed ID: 10079381
[TBL] [Abstract] [Full Text] [Related]
17. Serum serbb1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer.
Baron AT; Lafky JM; Boardman CH; Balasubramaniam S; Suman VJ; Podratz KC; Maihle NJ
Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):129-37. PubMed ID: 10067810
[TBL] [Abstract] [Full Text] [Related]
18. Oncogene patterns in breast and ovarian carcinomas.
Csókay B; Papp J; Besznyák I; Bösze P; Sárosi Z; Tóth J; Zalay Z; Oláh E
Eur J Surg Oncol; 1993 Dec; 19(6):593-9. PubMed ID: 7903645
[TBL] [Abstract] [Full Text] [Related]
19. Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressiveness.
Yamanaka Y; Friess H; Kobrin MS; Buchler M; Beger HG; Korc M
Anticancer Res; 1993; 13(3):565-9. PubMed ID: 8317885
[TBL] [Abstract] [Full Text] [Related]
20. Papillary thyroid carcinoma: the new, age-related TNM classification system in a retrospective analysis of 199 patients.
Kukkonen ST; Haapiainen RK; Franssila KO; Sivula AH
World J Surg; 1990; 14(6):837-41; discussion 841-2. PubMed ID: 2256356
[TBL] [Abstract] [Full Text] [Related]
